Orient Pharma Co., Ltd.(TW:4166)
NT$22.50+-0.05 (+2.27%)
TW:4166
Orient Pharma Co., Ltd. financials statements
NT$22.50
At close:+-0.05 (+2.27%)
Orient Pharma Co., Ltd. (4166) Financial Statements
Orient Pharma Co., Ltd. Financial Overview
Orient Pharma Co., Ltd.'s market cap is currently NT$5.47B. The company's EPS TTM is NT$0.99; its P/E ratio is 22.88; Orient Pharma Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.40B | NT$ 1.22B | NT$ 889.91M | NT$ 511.86M | NT$ 463.34M |
| Gross Profit | NT$ 706.92M | NT$ 651.56M | NT$ 468.67M | NT$ 155.35M | NT$ 142.67M |
| Operating Income | NT$ 261.06M | NT$ 157.91M | NT$ 27.75M | NT$ -33.73M | NT$ -104.39M |
| EBITDA | NT$ 396.67M | NT$ 312.81M | NT$ 172.40M | NT$ 35.37M | NT$ -39.21M |
| Net Income | NT$ 208.44M | NT$ 107.37M | NT$ 22.29M | NT$ -28.76M | NT$ -102.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 627.40M | NT$ 109.30M | NT$ 113.12M | NT$ 97.23M | NT$ 151.72M |
| Total Assets | NT$ 2.94B | NT$ 2.52B | NT$ 2.56B | NT$ 1.85B | NT$ 1.76B |
| Total Debt | NT$ 195.97M | NT$ 546.78M | NT$ 716.93M | NT$ 508.21M | NT$ 415.33M |
| Net Debt | NT$ -391.63M | NT$ 462.29M | NT$ 633.61M | NT$ 431.78M | NT$ 284.41M |
| Total Liabilities | NT$ 374.88M | NT$ 733.00M | NT$ 892.18M | NT$ 757.65M | NT$ 647.90M |
| Stockholders' Equity | NT$ 2.56B | NT$ 1.79B | NT$ 1.67B | NT$ 1.09B | NT$ 1.12B |
| Cash Flow | |||||
| Free Cash Flow | NT$ 324.32M | NT$ 169.60M | NT$ -176.51M | NT$ -17.54M | NT$ -123.56M |
| Operating Cash Flow | NT$ 360.13M | NT$ 197.01M | NT$ -102.99M | NT$ 11.38M | NT$ -53.56M |
| Investing Cash Flow | NT$ -73.07M | NT$ -22.48M | NT$ -88.02M | NT$ -29.09M | NT$ 55.81M |
| Financing Cash Flow | NT$ 217.75M | NT$ -173.36M | NT$ 197.90M | NT$ -36.79M | NT$ 79.11M |
Currency in TWD
